Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 single-arm prophylaxis study of SR604 in hemophilia A or B with or without inhibitors
CTR20263539Phase 3Active
- Sponsor
- Shanghai RAAS
- Start
- Sep 2026
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of SR604 in hemophilia A, hemophilia B (HB), sponsored by Shanghai RAAS. Started Sep 2026; status: active.
02
Drugs
SR604
03
Conditions
hemophilia Ahemophilia B (HB)
Beyond the preview
Go deeper on CTR20263539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263539.